You can help transform the future of head and neck cancer care
Each year, over 70,000 people in the U.S. are diagnosed with head and neck cancers — like thyroid, throat, mouth, and oral cancers. Your gift helps MSK advance care and develop better treatments for these complex cancers. Donate now to support lifesaving research.
Your support fuels breakthroughs
MSK is a trusted leader in head and neck cancer research and care. U.S. News & World Report ranked us as the #2 cancer hospital in the country, and Charity Navigator gave us its highest rating.
Together, we've made considerable progress
MSK’s unparalleled research and clinical expertise has led to new discoveries and treatment advances for many types of head and neck cancers, including:
And we’re creating even more hope for tomorrow
- Results from a phase 2 trial shared at the 2025 American Society of Clinical Oncology Annual Meeting showed promise for patients with advanced salivary gland cancers.
- A phase 3 clinical trial co-chaired by MSK radiation oncologist Nancy Lee, MD, led to the first FDA approval in nearly 20 years of a treatment for people with locally advanced head and neck squamous cell carcinoma.
Fund the next discovery in head and neck cancer research. You can also donate in honor or memory of a loved one.
Your generosity saves lives
Your gift today can power the next big breakthrough
With your support, MSK can continue leading the way forward in head and neck cancer research and care. Learn more about MSK’s innovations and advances — and the progress you fuel as an MSK Giving donor.
Improving care with AI
New artificial intelligence (AI) models developed at MSK are helping doctors make radiation treatments for people with head and neck cancers safer — and more effective.
See howOutsmarting metastasis
Dr. Nancy Lee, whose work is supported by MSK donors, discovered a potential new biomarker of distant metastasis (cancer spread far from the original tumor site) risk in people with head and neck squamous cell carcinoma.
Learn moreMaximizing quality of life
Many treatments for HPV-related throat cancer can have debilitating side effects that impact a person’s ability to eat and swallow. MSK doctors are pioneering new approaches that don’t sacrifice quality of life for efficacy.
See the latestTransform the future of head and neck cancer care worldwide
